Name: Surgical Options for the Treatment of Heart Failure (en Inglés)
Price: 2486.42 MXN
Availability: InStock
Author: Masters, R.
ISBN: 9789401741422

Envío gratis

portada Surgical Options for the Treatment of Heart Failure (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Masters, R.

Idioma

Inglés

N° páginas

198

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 1.2 cm

Peso

0.31 kg.

ISBN13

9789401741422

Categorías

Enfermedades cardiovasculares
Cirugía cardiotorácica
Cirugía de trasplantes

Surgical Options for the Treatment of Heart Failure (en Inglés)

Masters, R. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 2,486.42

$ 4,520.76

Ahorras: $ 2,034.34

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 05 de Agosto y el Viernes 16 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Surgical Options for the Treatment of Heart Failure (en Inglés)"

Despite the significant decline in heart disease mortaht>' rates over the last 25 years, heart failure has remained a significant problem. We are now confronted with large numbers of terminally ill patients for whom conventional therapies for heart failure have been exhausted and for whom repeated hospital visits are necessary. There now is a major thrust towards a management strategy which embraces a comprehensive approach including vigorous preventive measures and earlier surgical interventions. This book outlines the major surgical options for the treatment of heart failure and brings together a very broad base of opinions with contributions from several outstanding individuals. With the improved knowledge and techniques to control rejection, transplantation has become the central pillar in the surgical management of this group of patients. Unfortunately, because of limited donor supply the teclmique cannot be applied to large numbers of patients. A great deal of excitement, however, exists in the potential for xenotransplantation as a supplement to homotransplantation. The use of cardiac assist devices has become a reality with several hundred LVADS and BiVADS implanted throughout the world and cardiac replacement with total artificial hearts continues to be used successfully as a bridge to transplantation. We are on the thieshold of the broad application of assist devices to provide prolonged relief of heart failure and restore patients to an ambulatoiy home environment and hopefully return to the work force in significant numbers.